4 hours Ago By Defense World Staff
Ashland ( NYSE:ASH – Free Report ) had its price target trimmed by Wells Fargo & Company from $90.00 to $80.00 in a research note released on Thursday morning, Benzinga reports.
The firm currently has an overweight rating on the basic materials company’s stock. Several other research firms have also issued reports on ASH. BMO Capital Markets raised their price target on shares of Ashland from $83.
00 to $84.00 and gave the stock a “market perform” rating in a research report on Wednesday, December 11th. UBS Group decreased their target price on Ashland from $95.
00 to $93.00 and set a “buy” rating on the stock in a research report on Wednesday. Finally, StockNews.
com upgraded Ashland from a “hold” rating to a “buy” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $95.
57. Get Our Latest Research Report on Ashland Ashland Price Performance Ashland ( NYSE:ASH – Get Free Report ) last issued its quarterly earnings results on Tuesday, January 28th. The basic materials company reported $0.
28 EPS for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.51).
Ashland had a positive return on equity of 7.17% and a negative net margin of 1.12%.
During the same period last year, the business earned $0.45 EPS. Research analysts anticipate that Ashland will post 4.
31 EPS for the current year. Ashland Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Saturday, March 15th. Stockholders of record on Saturday, March 1st will be paid a $0.
405 dividend. The ex-dividend date is Friday, February 28th. This represents a $1.
62 annualized dividend and a dividend yield of 2.55%. Ashland’s dividend payout ratio is currently -245.
45%. Insider Transactions at Ashland In related news, SVP Robin E. Lampkin sold 868 shares of the stock in a transaction dated Friday, November 15th.
The shares were sold at an average price of $77.90, for a total transaction of $67,617.20.
Following the completion of the sale, the senior vice president now owns 2,883 shares in the company, valued at $224,585.70. This trade represents a 23.
14 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website . Also, VP Eric N.
Boni sold 451 shares of the business’s stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $78.07, for a total transaction of $35,209.
57. Following the completion of the transaction, the vice president now owns 14,182 shares in the company, valued at approximately $1,107,188.74.
This trade represents a 3.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here .
1.02% of the stock is currently owned by insiders. Hedge Funds Weigh In On Ashland A number of institutional investors and hedge funds have recently bought and sold shares of ASH.
Prospera Private Wealth LLC acquired a new stake in shares of Ashland in the third quarter valued at approximately $31,000. UMB Bank n.a.
boosted its position in Ashland by 193.1% in the 3rd quarter. UMB Bank n.
a. now owns 381 shares of the basic materials company’s stock valued at $33,000 after buying an additional 251 shares during the last quarter. Versant Capital Management Inc acquired a new stake in shares of Ashland in the 4th quarter valued at $33,000.
Wilmington Savings Fund Society FSB bought a new stake in shares of Ashland during the third quarter worth $38,000. Finally, Assetmark Inc. lifted its stake in shares of Ashland by 610.
5% during the third quarter. Assetmark Inc. now owns 540 shares of the basic materials company’s stock valued at $47,000 after acquiring an additional 464 shares during the period.
Institutional investors and hedge funds own 93.95% of the company’s stock. Ashland Company Profile ( Get Free Report ) Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally.
It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. Read More Five stocks we like better than Ashland Retail Stocks Investing, Explained ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains High Dividend REITs: Are They an Ideal Way to Diversify? Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead Investing in Construction Stocks Beyond Self-Driving Cars: Factory Automation Takes Center Stage Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.
com's FREE daily email newsletter ..
